Yu Fan’s CG Oncology CGON Stock Holding History

Yu Fan’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-163,456	Closed	-$4M	–	6
2025 Q1	$4M	Hold	163,456	–	–	4.11%	4
2024 Q4	$1.28M	Hold	163,456	–	–	2.41%	4
2024 Q3	$6.17M	Sell	163,456 -1,414,888	-90%	-$49.6M	18.99%	3
2024 Q2	$49.8M	Buy	+1,578,344	New	+$54.7M	65.11%	1

Other funds holding CGON

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Yu Fan's CGON Position: Q2 2025 in Review

Yu Fan sold out of CG Oncology (CGON) in Q2 2025, closing a stake of 163,456 shares — an estimated $4M sold.

Yu Fan first reported a position in CGON in Q2 2024 and held it in 4 quarters. The position peaked at $49.8M in Q2 2024. 162 funds tracked by Wall St. Rank hold CGON as of Q2 2025.

Yu Fan reported no remaining CG Oncology position as of Q2 2025 after selling out during the quarter.
Yu Fan sold 163,456 CG Oncology shares in Q2 2025, an estimated $4M.
Yu Fan first reported a position in CG Oncology in Q2 2024 and held it in 4 quarters.
Yu Fan's CG Oncology position peaked at $49.8M in Q2 2024.
162 funds tracked by Wall St. Rank held CG Oncology as of Q2 2025.

Based on Yu Fan's 13F filing for Q2 2025, filed 14 Aug 2025.